Biocon Biologics collaborates with National Cancer Society Malaysia
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The partnership combines Boehringer’s expertise in canine cardiology with Eko’s digital stethoscopes and AI algorithms
This strategic expansion marks a significant step in the company's global growth strategy
Globally, BRUKINSA is approved in more than 70 countries
The trial targets MCAS/MCAD, an under-recognized, debilitating condition with an unknown cause and no cure
Newly commissioned MCC in Jhagadia and Dahej and CCS project expansions will unlock an additional 8,800 MTPA, fuelling year-over-year revenue gains of 20%-30% in excipients
Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
Subscribe To Our Newsletter & Stay Updated